543 related articles for article (PubMed ID: 37072345)
41. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
42. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
[TBL] [Abstract][Full Text] [Related]
43. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
[TBL] [Abstract][Full Text] [Related]
44. PRV UL13 inhibits cGAS-STING-mediated IFN-β production by phosphorylating IRF3.
Bo Z; Miao Y; Xi R; Zhong Q; Bao C; Chen H; Sun L; Qian Y; Jung YS; Dai J
Vet Res; 2020 Sep; 51(1):118. PubMed ID: 32933581
[TBL] [Abstract][Full Text] [Related]
45. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
Vasiyani H; Wadhwa B; Singh R
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
[TBL] [Abstract][Full Text] [Related]
46. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
Anghelina D; Lam E; Falck-Pedersen E
J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
[TBL] [Abstract][Full Text] [Related]
47. Recent progress on the activation of the cGAS-STING pathway and its regulation by biomolecular condensation.
Yu X; Zhao Z; Jiang Z
J Mol Cell Biol; 2022 Nov; 14(6):. PubMed ID: 35803579
[TBL] [Abstract][Full Text] [Related]
48. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
[TBL] [Abstract][Full Text] [Related]
49. The Porcine Cyclic GMP-AMP Synthase-STING Pathway Exerts an Unusual Antiviral Function Independent of Interferon and Autophagy.
Jiang S; Xia N; Luo J; Zhang Y; Cao Q; Zhang J; Wang Y; Zhao Y; Zheng W; Chen N; Meurens F; Li X; Zhu J
J Virol; 2022 Dec; 96(23):e0147622. PubMed ID: 36377876
[TBL] [Abstract][Full Text] [Related]
50. cGAS/STING/TBK1/IRF3 Signaling Pathway Activates BMDCs Maturation Following
Li Q; Liu C; Yue R; El-Ashram S; Wang J; He X; Zhao D; Zhou X; Xu L
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791397
[TBL] [Abstract][Full Text] [Related]
51. cGAS-Mediated Innate Immunity Spreads Intercellularly through HIV-1 Env-Induced Membrane Fusion Sites.
Xu S; Ducroux A; Ponnurangam A; Vieyres G; Franz S; Müsken M; Zillinger T; Malassa A; Ewald E; Hornung V; Barchet W; Häussler S; Pietschmann T; Goffinet C
Cell Host Microbe; 2016 Oct; 20(4):443-457. PubMed ID: 27736643
[TBL] [Abstract][Full Text] [Related]
52. cGAS-STING Pathway Activation during Trypanosoma cruzi Infection Leads to Tissue-Dependent Parasite Control.
Perumal N; White B; Sanchez-Valdez F; Tarleton RL
J Immunol; 2023 Oct; 211(7):1123-1133. PubMed ID: 37603014
[TBL] [Abstract][Full Text] [Related]
53. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
[TBL] [Abstract][Full Text] [Related]
54. cGAS-STING effectively restricts murine norovirus infection but antagonizes the antiviral action of N-terminus of RIG-I in mouse macrophages.
Yu P; Miao Z; Li Y; Bansal R; Peppelenbosch MP; Pan Q
Gut Microbes; 2021; 13(1):1959839. PubMed ID: 34347572
[TBL] [Abstract][Full Text] [Related]
55. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
Zhang J; Yu S; Peng Q; Wang P; Fang L
Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
[TBL] [Abstract][Full Text] [Related]
56.
Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
[TBL] [Abstract][Full Text] [Related]
57. Total glucosides of paeony alleviates cGAS-STING-mediated diseases by blocking the STING-IRF3 interaction.
Xiu Y; Wang S; Zhang P; Li C; Wu Z; Wen J; Xu Y; Lv G; Zhao X; Dong X; Chen Y; Li J; Wang Y; Zou L; Xiao X; Bai Z
Chin J Nat Med; 2024 May; 22(5):402-415. PubMed ID: 38796214
[TBL] [Abstract][Full Text] [Related]
58. Role of the cGAS-STING pathway in systemic and organ-specific diseases.
Skopelja-Gardner S; An J; Elkon KB
Nat Rev Nephrol; 2022 Sep; 18(9):558-572. PubMed ID: 35732833
[TBL] [Abstract][Full Text] [Related]
59. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
60. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
